BiotechTube
Metofico

Metofico

London, United Kingdom· Est.
metofico.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Metofico is a private, early-stage biotech software company providing an AI-powered, no-code analysis platform for pre-clinical research data. Its core products include TOMB-AI for automated behavior recognition and tracking, and FPA for fiber photometry data analysis, which are used by researchers to streamline workflows and enhance research outcomes. Backed by notable accelerators like Y-Combinator and Sterling Road, the company is positioned to capitalize on the growing need for advanced data analysis tools in academia and biopharma R&D. Metofico operates a Software-as-a-Service (SaaS) business model and is in an early revenue stage, focusing on user adoption and platform expansion.

AI / Machine LearningDrug Delivery

Technology Platform

No-code, AI-powered online platform for automated pre-clinical data analysis, featuring modules for video-based behavior recognition (TOMB-AI) and fiber photometry data analysis (FPA).

Opportunities

The growing data deluge in life sciences research creates a strong demand for automated, user-friendly analysis tools.
Expansion into the biopharma and CRO sectors offers a path to larger contracts and recurring revenue.
The platform model allows for continuous addition of new analysis modules, increasing addressable market and customer lifetime value.

Risk Factors

Facing competition from both established research software and new AI entrants, requiring continuous innovation.
Convincing researchers to adopt new tools and abandon legacy methods presents a significant adoption hurdle.
Monetization in the budget-constrained academic market can be challenging, necessitating a successful pivot to commercial customers.

Competitive Landscape

Metofico competes with specialized software like Noldus EthoVision, DeepLabCut, and commercial analysis packages from hardware vendors (e.g., Tucker-Davis Technologies, Neurophotometrics). Its key differentiators are its integrated, no-code cloud platform and its focus on ease-of-use for non-programmers. It also faces potential competition from general-purpose AI/ML platforms adapted for life sciences.

More companies in United Kingdom →